A new study has shown that reduced adenosine kinase expression (ADK) in the liver can make it more susceptible to carcinogenic damage and the development of liver cancer. Combined results from the study of human liver cancer ...
Apr 10, 2019
0
1
Hepatitis B is a viral liver infection that can lead to acute or chronic conditions. Although there is a vaccine that offers protection against the virus, current treatments which prevent the virus from replicating are not ...
Apr 9, 2019
0
22
Hepatocellular carcinoma (HCC) is a long medical name for the most common form of liver cancer, a malignancy whose incidence has nearly doubled over the past decade, making it the fastest growing type of cancer in the U.S., ...
Apr 8, 2019
0
10
A new study reveals that rising rates of liver cancer deaths in the United States have largely been confined to individuals who have received less education, especially among men. Published early online in Cancer, a peer-reviewed ...
Apr 8, 2019
0
1
The buildup of fat in the liver known as fatty liver disease sometimes leads to hard-to-treat liver cancer. Scientists don't understand why the cancer risk is higher for fatty liver disease caused by excessive alcohol consumption ...
Apr 7, 2019
0
4
Researchers in Spain have discovered that a hormone secreted by fat cells that is present at higher levels in women can stop liver cells from becoming cancerous. The study, which will be published April 3 in the Journal of ...
Apr 3, 2019
1
90
Blood platelets that interact with liver cells and immune cells play a major role in the development of fatty liver disease, non-alcoholic fatty liver inflammation and liver cancer, scientists from the German Cancer Research ...
Apr 1, 2019
1
17
Current World Health Organization (WHO) guidelines for chronic hepatitis B (CHB) fail to detect half of the patients in need of treatment in Ethiopia, report scientists in the Journal of Hepatology, published by Elsevier. ...
Mar 28, 2019
0
1
Researchers from Duke-NUS Medical School, Singapore General Hospital (SGH) and Lion TCR have demonstrated that they were able to engineer HBV-specific T cells, a type of immune cells found in the body, to treat Hepatocellular ...
Mar 28, 2019
0
3
Even as overall cancer incidence and mortality decrease in the United States, the number of people diagnosed with liver cancer is on the rise. Current therapies for liver cancer are largely ineffective, resulting in poor ...
Mar 13, 2019
0
0
